SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cal Gary who wrote (9823)6/17/2002 12:20:30 PM
From: Joe Krupa  Read Replies (2) of 14101
 
Hi Cal,

Yup, I saw that. I may be accused of being paranoid here, but I'm convinced that somebody at the Globe & Mail has it in for Dimethaid, in particular a person with the initials LZ. I have no proof of this but the reporting history of that paper certainly suggests a bias.

First the paper sees fit to announce a few months back, in bold headline nonetheless, that Glen Sather sells a few thousand shares. Then DMX acquires the massive potential WF10 pipeline through the Oxo takeover - perhaps what will become one of the most revolutionary drugs ever brought to market by a Cdn. company - and not a whisper in the Globe. Now they publish a blurb that indicates that sales in the UK have been disappointing to date.

This same pattern extends back much further, but these are some recent examples.

Go figure.

joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext